Send the following on WhatsApp
Continue to ChatPomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial - https://avesis.ogu.edu.tr/yayin/71de211f-a72b-4faf-8e4a-d843969078ae/pomalidomide-bortezomib-and-dexamethasone-for-patients-with-relapsed-or-refractory-multiple-myeloma-previously-treated-with-lenalidomide-optimismm-a-randomised-open-label-phase-3-trial